Published in Drug Week, March 26th, 2004
Net sales for the quarter ended December 31, 2003, were $ 10.7 million, an increase of $836,000, or 8.5% compared to net sales for the quarter ended December 31, 2002. The company's revenues benefited by a $571,000 positive impact of foreign exchange for the quarter ended December 31, 2003, when compared to the quarter ended December 31, 2002.
For the 3 months ended December 31, 2003, sales of the company's Signaling product lines grew 24% compared to the prior year quarter, from $1,900,000 to $2,400,000. The company's sales...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.